Recent studies have also highlighted the importance of the tumor micro-environment, such as stromal cells, in breast cancer prognosis and chemotherapy efficacy, particularly within the HER2-positive subgroup [24, 25, 27]. Here, ERBB2 is linked to neoplasm.